These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 8446368

  • 21. Proliferative vitreo-retinal disorders: experimental models in vivo and in vitro.
    Martini B.
    Acta Ophthalmol Suppl (1985); 1992; (201):1-63. PubMed ID: 1322004
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Thrombin Generation in Vitreous and Subretinal Fluid of Patients with Retinal Detachment.
    Mulder VC, Bastiaans J, van Leuven CJM, van Meurs JC, Kluft C.
    Ophthalmologica; 2018; 240(1):23-28. PubMed ID: 29617690
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Vitreous aspirates from patients with proliferative vitreoretinopathy stimulate retinal pigment epithelial cell migration.
    Campochiaro PA, Jerdan JA, Glaser BM, Cardin A, Michels RG.
    Arch Ophthalmol; 1985 Sep; 103(9):1403-5. PubMed ID: 4038135
    [Abstract] [Full Text] [Related]

  • 26. High subretinal fluid procoagulant activity in rhegmatogenous retinal detachment.
    Ricker LJ, Dieri RA, Beckers GJ, Pels E, Liem AT, Hendrikse F, Kijlstra A, Hemker HC, La Heij EC.
    Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5234-9. PubMed ID: 20435588
    [Abstract] [Full Text] [Related]

  • 27. Vitreous and subretinal fluid concentrations of orally administered dabigatran in patients with rhegmatogenous retinal detachment.
    Mulder VC, Kluft C, van Meurs JC.
    Acta Ophthalmol; 2016 Nov; 94(7):663-667. PubMed ID: 27496339
    [Abstract] [Full Text] [Related]

  • 28. Correlation of transforming growth factor β-1 vitreous levels with clinical severity of proliferative vitreoretinopathy in patients with rhegmatogenous retinal detachment.
    Palomares-Ordóñez JL, Sánchez-Ramos JA, Ramírez-Estudillo JA, Robles-Contreras A.
    Arch Soc Esp Oftalmol (Engl Ed); 2019 Jan; 94(1):12-17. PubMed ID: 30309666
    [Abstract] [Full Text] [Related]

  • 29. Pathogenesis of proliferative vitreoretinopathy. Modulation of retinal pigment epithelial cell functions by vitreous and macrophages.
    Kirchhof B, Sorgente N.
    Dev Ophthalmol; 1989 Jan; 16():1-53. PubMed ID: 2676632
    [Abstract] [Full Text] [Related]

  • 30. Activation of neural progenitor cells in human eyes with proliferative vitreoretinopathy.
    Johnsen EO, Frøen RC, Albert R, Omdal BK, Sarang Z, Berta A, Nicolaissen B, Petrovski G, Moe MC.
    Exp Eye Res; 2012 May; 98():28-36. PubMed ID: 22465407
    [Abstract] [Full Text] [Related]

  • 31. Active scatter factor (HGF/SF) in proliferative vitreoretinal disease.
    Briggs MC, Grierson I, Hiscott P, Hunt JA.
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3085-94. PubMed ID: 10967068
    [Abstract] [Full Text] [Related]

  • 32. The role of thrombin in proliferative vitreoretinopathy.
    Bastiaans J, van Meurs JC, Mulder VC, Nagtzaam NM, Smits-te Nijenhuis M, Dufour-van den Goorbergh DC, van Hagen PM, Hooijkaas H, Dik WA.
    Invest Ophthalmol Vis Sci; 2014 Jul 11; 55(7):4659-66. PubMed ID: 25015355
    [Abstract] [Full Text] [Related]

  • 33. Levels of some cytokines in subretinal fluid in proliferative vitreoretinopathy and rhegmatogenous retinal detachment.
    Kenarova B, Voinov L, Apostolov C, Vladimirova R, Misheva A.
    Eur J Ophthalmol; 1997 Jul 11; 7(1):64-7. PubMed ID: 9101198
    [Abstract] [Full Text] [Related]

  • 34. Comparison of Chemokine CXCL-1 and Interleukin-6 Concentrations in the Subretinal Fluid and Vitreous in Rhegmatogenous Retinal Detachment.
    Symeonidis C, Rotsos T, Matsou A, Dermenoudi M, Georgalas I, Tsinopoulos I, Makri O, Souliou E, Dimitrakos SA.
    Ocul Immunol Inflamm; 2021 Feb 17; 29(2):355-361. PubMed ID: 31661651
    [Abstract] [Full Text] [Related]

  • 35. Comparison of interleukin IL-6 levels in the subretinal fluid and the vitreous during rhegmatogenous retinal detachment.
    Symeonidis C, Androudi S, Tsaousis KT, Tsinopoulos I, Brazitikos P, Diza E, Dimitrakos SA.
    Cytokine; 2012 Jan 17; 57(1):17-8. PubMed ID: 22070971
    [No Abstract] [Full Text] [Related]

  • 36. Oxytalan fibres in proliferative vitreoretinopathy.
    Alexander RA, Hiscott P, McGalliard J, Grierson I.
    Ger J Ophthalmol; 1992 Jan 17; 1(6):382-7. PubMed ID: 1490137
    [Abstract] [Full Text] [Related]

  • 37. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M, Kabatas EU, Batman C, Akin KO, Kabatas N.
    Ophthalmic Res; 2012 Jan 17; 47(1):7-12. PubMed ID: 21691136
    [Abstract] [Full Text] [Related]

  • 38. Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye.
    Connor TB, Roberts AB, Sporn MB, Danielpour D, Dart LL, Michels RG, de Bustros S, Enger C, Kato H, Lansing M.
    J Clin Invest; 1989 May 17; 83(5):1661-6. PubMed ID: 2708527
    [Abstract] [Full Text] [Related]

  • 39. Apoptosis in proliferative vitreoretinal disorders: possible involvement of TGF-beta-induced RPE cell apoptosis.
    Esser P, Heimann K, Bartz-schmidt KU, Fontana A, Schraermeyer U, Thumann G, Weller M.
    Exp Eye Res; 1997 Sep 17; 65(3):365-78. PubMed ID: 9299173
    [Abstract] [Full Text] [Related]

  • 40. The role of fibronectin, laminin, vitronectin and their receptors on cellular adhesion in proliferative vitreoretinopathy.
    Casaroli Marano RP, Vilaró S.
    Invest Ophthalmol Vis Sci; 1994 May 17; 35(6):2791-803. PubMed ID: 7514582
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.